Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05356702 · ClinicalTrials.gov registry record · NA
The Brain Health Study: A Pragmatic, Patient-Centered Trial
A NA study of Alzheimer Disease and Dementia, sponsored by Kaiser Permanente.
- Active
- Registry status
- NA
- Development phase
- 3,417
- Enrollment target
- 5
- Study locations
NCT05356702: Active NA study of Alzheimer Disease and Dementia, sponsored by Kaiser Permanente.
NCT05356702 is a NA study of Alzheimer Disease and Dementia that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 3,417 participants, above the 2,740-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (25% higher). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05356702, a NA study of Alzheimer Disease and Dementia, is active but no longer recruiting, sponsored by Kaiser Permanente.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3,417 participants
- Enrollment target
- 5
- Study locations
Study Summary
The eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.
Primary Outcome
Rate of new dementia diagnoses identified from the electronic health record (EHR) using a prespecified set of ICD-10 codes
Conditions Studied
Interventions
- OTHER Brain Health Assessment
Study Locations (5)
Washington
- Kaiser Permanente Burien Medical Center - Burien
- Kaiser Permanente Kent Medical Center - Kent
- Kaiser Permanente Renton Medical Center - Renton
- Kaiser Permanente, Capitol Hill - Seattle
- Kaiser Permanente Northgate Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,417 participants |
| Start Date | 2022-06-29 |
| Est. Completion | 2025-04-15 |
| Phase | NA |
What the registry record for NCT05356702 still lists
NCT05356702 is an interventional study that assigns participants to a tested intervention. Its 3,417 participants enrollment target places it among the larger protocols in the corpus, above the 2,740-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (25% higher).
The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Brain Health Assessment is the first listed.
NCT05356702 lists 5 locations in 1 state (Washington).
Frequently Asked Questions
What is clinical trial NCT05356702 about?
NCT05356702 is a clinical study titled "The Brain Health Study: A Pragmatic, Patient-Centered Trial". The eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.
What is the current status of trial NCT05356702?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,417 participants. The study started on 2022-06-29. Estimated completion is 2025-04-15.
What conditions does trial NCT05356702 study?
This clinical trial studies the following conditions: Alzheimer Disease, Dementia.
What interventions are being tested in trial NCT05356702?
The interventions under investigation include: Brain Health Assessment (OTHER).
Who is sponsoring clinical trial NCT05356702?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05356702 being conducted?
This trial has 5 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05356702's enrollment target sits among peer trials
3,417 16th of 306 higher than 291 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03474029 · 3,400 participants · Phase 2
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
- NCT06880055 · 3,375 participants
Shield Post-Approval Study Protocol
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI